AMTX / Aemetis, Inc. - Pemfailan SEC, Laporan Tahunan, Penyata Proksi

Aemetis, Inc.
US ˙ NasdaqGM ˙ US00770K2024

Statistik Asas
LEI 254900DQF4U5U9W7AR72
CIK 738214
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Aemetis, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan senarai kronologi lengkap bagi Pemfailan SEC, tidak termasuk pemfailan pemilikan yang kami sediakan di tempat lain.
August 7, 2025 EX-99.1

Aemetis Reports Second Quarter 2025 Financial Results

Exhibit 99.1 ` External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 [email protected] Aemetis Reports Second Quarter 2025 Financial Results ● Revenue increased $9.3M from the first quarter of 2025 to $52.2M, driven by the restart of India biodiesel deliveries under new orde

August 7, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 Aemetis, Inc. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Numbe

August 7, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO S

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36475 Aem

May 16, 2025 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2025 Aemetis, Inc. Exact name of registrant as specified in its charter Delaware 001-36475 26-1407544 State or other jurisdiction of incorporation Commission File Number IRS E

May 8, 2025 EX-99.1

Aemetis Reports First Quarter 2025 Financial Results

Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 [email protected] Aemetis Reports First Quarter 2025 Financial Results ● California Ethanol passes $2 billion cumulative revenue milestone. ● Aemetis Biogas increased sales by 10,100 MMBtu compared with same

May 8, 2025 EX-10.1

Ninth Waiver and Amendment to Series A Preferred Unit Purchase Agreement, entered effective April 30, 2025, between Aemetis Biogas LLC, Protair-X Technologies Inc., and the Third Eye Capital Corporation

Exhibit 10.1 NINTH WAIVER AND AMENDMENT TO SERIES A PREFERRED UNIT PURCHASE AGREEMENT This Ninth Waiver and Amendment to Series A Preferred Unit Purchase Agreement (this “Amendment”), effective as of April 30, 2025 (“Effective Date”), is made by and among (i) AEMETIS BIOGAS LLC, a Delaware limited liability company (“ABGL” or “COMPANY”), (ii) PROTAIR-X TECHNOLOGIES INC., a Canadian corporation (th

May 8, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2025 Aemetis, Inc. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2025 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Number)

May 8, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36475 Ae

April 2, 2025 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e

March 14, 2025 EX-FILING FEES

Filing Fee Table

Exhibit 107 CALCULATION OF REGISTRATION FEE Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount to be Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value $0.

March 14, 2025 EX-10.67

Promissory Note, dated March 11, 2025, issued by Goodland Advanced Fuels, Inc. and Aemetis Carbon Capture, Inc. to Third Eye Capital Corporation.

Exhibit 10.67 PROMISSORY NOTE March 12, 2025 FOR VALUE RECEIVED, the undersigned, GOODLAND ADVANCED FUELS, INC., a Delaware corporation and AEMETIS CARBON CAPTURE, INC. (collectively, the “Borrowers”) jointly and severally promise to pay to the order of THIRD EYE CAPITAL CORPORATION (the “Lender”) the Principal Amount as set forth below, at its offices or such other place as the Lender may designa

March 14, 2025 EX-21

Subsidiaries of the Registrant

Exhibit 21 List of Subsidiaries (Name and State of Formation) Aemetis Advanced Biorefinery Keyes, Inc.

March 14, 2025 S-8

As filed with the Securities and Exchange Commission on March 14, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Aemetis, Inc. (Exac

As filed with the Securities and Exchange Commission on March 14, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Aemetis, Inc. (Exact name of registrant as specified in its charter) 20400 Stevens Creek Blvd., Suite 700, Cupertino, California 95014 (408) 213-0940 (Address and teleph

March 14, 2025 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-36475 Aemetis, Inc. (Exact name

March 14, 2025 EX-10.66

Amendment and Waiver No. 6 to Credit Agreement, effective as of March 11, 2025, by and among Goodland Advanced Fuels, Inc., Aemetis Carbon Capture, Inc., and Third Eye Capital Corporation, as agent for MBI/TEC Private Debt Opportunities Fund II, LP, and acknowledged and agreed by the guarantors listed on the signature page thereto.

Exhibit 10.66 AMENDMENT AND WAIVER NO. 6 TO CREDIT AGREEMENT This Amendment and Waiver No. 6 to Credit Agreement (this “Amendment”), is signed March 12, 2025 and dated effective as of March 1, 2025 (the “Effective Date”), by and among (i) GOODLAND ADVANCED FUELS, INC., a Delaware corporation and AEMETIS CARBON CAPTURE, INC. (each, a “Borrower”) and (ii) THIRD EYE CAPITAL CORPORATION, an Ontario co

March 14, 2025 EX-19

Insider Trading Policy

Exhibit 19 INSIDER TRADING POLICY Revised as of March 16, 2023 This Insider Trading Policy (the “Policy”) provides guidelines to employees, officers and directors of Aemetis, Inc.

March 14, 2025 EX-10.52

Eighth Waiver and Amendment to Series A Preferred Unit Purchase Agreement, effective as of January 31, 2025, by and among Aemetis Biogas LLC, Protair-X Technologies Inc. and Third Eye Capital Corporation.

Exhibit 10.52 EIGHTH WAIVER AND AMENDMENT TO SERIES A PREFERRED UNIT PURCHASE AGREEMENT This Eighth Waiver and Amendment to Series A Preferred Unit Purchase Agreement (this “Amendment”), effective as of January 31, 2025 (“Effective Date”) , is made by and among (i) AEMETIS BIOGAS LLC, a Delaware limited liability company (“ABGL” or “COMPANY”), (ii) PROTAIR-X TECHNOLOGIES INC., a Canadian corporati

March 13, 2025 EX-99.1

Aemetis Reports 2024 Fourth Quarter and Year-End Results Annual Revenues Increased 43% to $268 million

Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Contact: Todd Waltz Chief Financial Officer (408) 213-0925 [email protected] Aemetis Reports 2024 Fourth Quarter and Year-End Results Annual Revenues Increased 43% to $268 million ● India biodiesel annual revenues increased 20% to $93 million. ● India biodiesel annual pro

March 13, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 13, 2025 Aemetis, Inc. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 13, 2025 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Numbe

February 28, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2025 Aemetis, Inc. E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2025 Aemetis, Inc. Exact name of registrant as specified in its charter Delaware 001-36475 26-1407544 State or other jurisdiction of incorporation Commission File Number

February 19, 2025 EX-1.3

Letter Agreement, dated February 12, 2025, by and between Aemetis, Inc. and H.C. Wainwright & Co., LLC

EXHIBIT 1.3 February 12, 2025 Aemetis, Inc. 20400 Stevens Creek Blvd, Suite 700 Cupertino, California 95014 Attention: Eric McAfee Dear Mr. McAfee: Reference is made to the At Market Issuance Sales Agreement, dated as of January 26, 2021, as amended on August 18, 2021 (the “ATM Agreement”), between Aemetis, Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”). This letter (the “Amend

February 19, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 12, 2025 Aemetis, Inc. E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 12, 2025 Aemetis, Inc. Exact name of registrant as specified in its charter Delaware 001-36475 26-1407544 State or other jurisdiction of incorporation Commission File Number

February 12, 2025 424B5

Aemetis, Inc. Common Stock

Filed Pursuant to Rule 424(b)(5) Registration No. 333-281457 PROSPECTUS SUPPLEMENT (To Prospectus dated February 11, 2025) Aemetis, Inc. Common Stock $210,000,000 We have entered into an At Market Issuance Sales Agreement, or the sales agreement, with H.C. Wainwright & Co., LLC (the "distribution agent"), dated January 26, 2021, as amended from time to time through the date of this prospectus supp

February 7, 2025 CORRESP

Aemetis, Inc. 20400 Stevens Creek Blvd., Suite 700 Cupertino, CA 95014

Aemetis, Inc. 20400 Stevens Creek Blvd., Suite 700 Cupertino, CA 95014 February 7, 2025 Via EDGAR Transmission U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-6010 Attn: Nicholas O’Leary Re: Aemetis, Inc. Registration Statement on Form S-3 Filed August 9, 2024, as amended February 4, 2025 File No. 333-281457 Dear Mr. O’Leary: In acc

February 4, 2025 S-3/A

As filed with the Securities and Exchange Commission on February 4, 2025 Registration No. 333-281457 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT O

As filed with the Securities and Exchange Commission on February 4, 2025 Registration No.

February 4, 2025 EX-FILING FEES

Filing Fee Calculation

EXHIBIT 107 CALCULATION OF FILING FEE TABLE Form S-3 (Form Type) Aemetis, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit (2) Maximum Aggregate Offering Price Fee Rate Amount of Registra

January 23, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 16, 2025 Aemetis, Inc. Ex

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 16, 2025 Aemetis, Inc. Exact name of registrant as specified in its charter Delaware 001-36475 26-1407544 State or other jurisdiction of incorporation Commission File Number I

November 12, 2024 EX-99.1

Aemetis Reports Revenues of $81 Million for the Third Quarter 2024 Revenues increased 19% over the Third Quarter of 2023

Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 [email protected] Aemetis Reports Revenues of $81 Million for the Third Quarter 2024 Revenues increased 19% over the Third Quarter of 2023 CUPERTINO, Calif. – November 12, 2024 - Aemetis, Inc. (NASDAQ: AMTX),

November 12, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-3647

November 12, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2024 Aemetis, Inc. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2024 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Nu

November 12, 2024 EX-10.1

Seventh Waiver and Amendment to Series A Preferred Unit Purchase Agreement, effective as of August 31, 2024, and entered by Aemetis Biogas LLC, Protair-X Technologies Inc., and Third Eye Capital Corporation.

EXHIBIT 10.1 SEVENTH WAIVER AND AMENDMENT TO SERIES A PREFERRED UNIT PURCHASE AGREEMENT This SEVENTH Waiver and Amendment to Series A Preferred Unit Purchase Agreement (this “Amendment”), effective as of August 31, 2024 (“Effective Date”), is made by and among (i) AEMETIS BIOGAS LLC, a Delaware limited liability company (“ABGL” or “COMPANY”), (ii) PROTAIR-X TECHNOLOGIES INC., a Canadian corporatio

August 9, 2024 S-3

As filed with the Securities and Exchange Commission on August 9, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Aemetis, Inc. (Exact

As filed with the Securities and Exchange Commission on August 9, 2024 Registration No.

August 9, 2024 EX-FILING FEES

Filing Fee Calculation

EXHIBIT 107 CALCULATION OF FILING FEE TABLE Form S-3 (Form Type) Aemetis, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit (2) Maximum Aggregate Offering Price Fee Rate Amount of Registra

August 5, 2024 EX-10.1

Amendment No. 29 to Amended and Restated Note Purchase Agreement, dated July 31, 2024, and entered by Aemetis Advanced Fuels Keyes, Inc, Aemetis Facility Keyes, Inc., Aemetis, Inc., Third Eye Capital Corporation, and certain note holders specified therein.

EXHIBIT 10.1 AMENDMENT NO. 29 TO AMENDED AND RESTATED NOTE PURCHASE AGREEMENT This Amendment No. 29 to Amended and Restated Note Purchase Agreement (this “Amendment”) dated July 31, 2024, is made by and among (i) AEMETIS ADVANCED FUELS KEYES, INC., a Delaware corporation (“AEFK”), AEMETIS FACILITY KEYES, INC., a Delaware corporation (“Keyes Facility”, together with AEFK, the “Borrowers”), AEMETIS,

August 5, 2024 EX-10.2

Sixth Waiver and Amendment to Series A Preferred Unit Purchase Agreement, effective as of April 30, 2024, and entered by Aemetis Biogas LLC, Protair-X Technologies Inc., and Third Eye Capital Corporation.

EXHIBIT 10.2 SIXTH WAIVER AND AMENDMENT TO SERIES A PREFERRED UNIT PURCHASE AGREEMENT This Sixth Waiver and Amendment to Series A Preferred Unit Purchase Agreement (this “Amendment”), effective as of April 30, 2024 (“Effective Date”), is made by and among (i) AEMETIS BIOGAS LLC, a Delaware limited liability company (“ABGL” or “COMPANY”), (ii) PROTAIR-X TECHNOLOGIES INC., a Canadian corporation (th

August 5, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO S

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36475 Aem

August 1, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2024 Aemetis, Inc. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2024 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Numbe

August 1, 2024 EX-99.1

Aemetis Reports Revenues of $66 Million for the Second Quarter 2024 Revenues increased 48% over the Second Quarter of 2023

Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 [email protected] Aemetis Reports Revenues of $66 Million for the Second Quarter 2024 Revenues increased 48% over the Second Quarter of 2023 CUPERTINO, Calif. – August 1, 2024 - Aemetis, Inc. (NASDAQ: AMTX),

May 31, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2024 Aemetis, Inc. Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2024 Aemetis, Inc. Exact name of registrant as specified in its charter Delaware 001-36475 26-1407544 State or other jurisdiction of incorporation Commission File Number IRS E

May 9, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36475 Ae

May 9, 2024 EX-99.1

Aemetis Reports First Quarter 2024 Financial Results

Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 [email protected] Aemetis Reports First Quarter 2024 Financial Results CUPERTINO, Calif. – May 9, 2024 - Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels company focused on low and ne

May 9, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2024 Aemetis, Inc. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2024 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Number)

April 29, 2024 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e

April 19, 2024 PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e

March 29, 2024 EX-97

Policy Relating to Recovery of Erroneously Awarded Compensation

Exhibit 97 Aemetis, Inc. Policy for the Recovery of Erroneously Awarded Compensation (“Clawback Policy”) Adopted January 18, 2024 A. Overview In accordance with the applicable rules of The Nasdaq Stock Market (the “Nasdaq Rules”), Section 10D and Rule 10D-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (“Rule 10D-1”), the Board of Directors (the “Board”) of Aemetis, Inc.

March 29, 2024 EX-21

Subsidiaries of the Registrant

Exhibit 21.1 List of Subsidiaries (Name and State of Formation) Aemetis Advanced Biorefinery Keyes, Inc. (Delaware) Aemetis Advanced Fuels, Inc. (Nevada) Aemetis Advanced Products Keyes, Inc. (Delaware) Aemetis Health Products, Inc. (Delaware) Aemetis Properties Riverbank, Inc. (Delaware) Aemetis Riverbank, Inc. (Delaware) Aemetis Advanced Products Riverbank, Inc. (Delaware) Aemetis Americas, Inc.

March 29, 2024 EX-FILING FEES

CALCULATION OF REGISTRATION FEE

Exhibit 107 CALCULATION OF REGISTRATION FEE Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount to be Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value $0.

March 29, 2024 EX-10.37

Seventh Amended and Restated Promissory Note, dated March 25, 2024, by and among Aemetis, Inc.; Aemetis Advanced Fuels Keyes, Inc.; Aemetis Facility Keyes, Inc.; Third Eye Capital Corporation; and Third Eye Capital Management Inc.

Exhibit 10.37 SEVENTH AMENDED AND RESTATED PROMISSORY NOTE March 25, 2024 FOR VALUE RECEIVED, the undersigned, AEMETIS ADVANCED FUELS KEYES, INC., a Delaware corporation (“AAFK”), AEMETIS FACILITY KEYES, INC., a Delaware corporation (“Keyes Facility”, and together with AAFK, “Borrowers”) and AEMETIS, INC., a Delaware corporation (“Parent”, and together with Borrowers, the “Obligors”) jointly and s

March 29, 2024 EX-10.36

Limited Waiver and Amendment No. 28 to Amended and Restated Note Purchase Agreement, dated as of March 25, 2024, by and among Aemetis, Inc.; Aemetis Advanced Fuels Keyes, Inc.; Aemetis Facility Keyes, Inc.; and Third Eye Capital Corporation

Exhibit 10.36 LIMITED WAIVER AND AMENDMENT NO. 28 TO AMENDED AND RESTATED NOTE PURCHASE AGREEMENT This Limited Waiver and Amendment No. 28 to Amended and Restated Note Purchase Agreement (this “Amendment”), is dated as of March 25, 2024, is made by and among (i) AEMETIS ADVANCED FUELS KEYES, INC., a Delaware corporation (“AEFK”), AEMETIS FACILITY KEYES, INC., a Delaware corporation (“Keyes Facilit

March 29, 2024 S-8

As filed with the Securities and Exchange Commission on March 29, 2024. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Aemetis, Inc. (Exac

As filed with the Securities and Exchange Commission on March 29, 2024. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Aemetis, Inc. (Exact name of registrant as specified in its charter) 20400 Stevens Creek Blvd., Suite 700, Cupertino, California 95014 (408) 213-0940 (Name, address, and

March 29, 2024 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-36475 Aemetis, Inc. (Exact name

March 15, 2024 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Check One: ☑ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Peri

March 7, 2024 EX-99.1

Aemetis Reports 2023 Fourth Quarter and Year-End Results India biodiesel segment reports $77.2 million of annual sales, an increase of 175% over prior year

Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Contact: Todd Waltz Chief Financial Officer (408) 213-0925 [email protected] Aemetis Reports 2023 Fourth Quarter and Year-End Results India biodiesel segment reports $77.2 million of annual sales, an increase of 175% over prior year CUPERTINO, Calif. – March 7, 2024 – Aem

March 7, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 7, 2024 Aemetis, Inc. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 7, 2024 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Number

February 20, 2024 EX-99.2

Aemetis, Inc. (NASDAQ: AMTX): Leading the Production of Below Zero Carbon Intensity Renewable Natural Gas and Renewable Fuels for Airplanes, Cars, Trucks, and Electric Vehicles, February 20, 2024

Exhibit 99.2

February 20, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 20, 2024 Aemetis, Inc. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 20, 2024 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 State or other jurisdiction of incorporation Commission File Numbe

February 20, 2024 EX-99.1

Aemetis Announces Updated Five Year Plan Projecting Growth to $1.95 Billion of Revenue and $645 Million of Adjusted EBITDA in 2028

External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 ksmith@pcgadvisory.

February 16, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 15, 2024 Aemetis, Inc. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 15, 2024 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 State or other jurisdiction of incorporation Commission File Numbe

February 14, 2024 SC 13G/A

AMTX / Aemetis, Inc. / Encompass Capital Advisors LLC Passive Investment

SC 13G/A 1 encompass-amtx123123.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 3)* Aemetis, Inc. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 00770K202 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the approp

February 14, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2024 Aemetis, Inc. (E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2024 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 State or other jurisdiction of incorporation Commission File Number

February 14, 2024 SC 13G/A

AMTX / Aemetis, Inc. / ALLIANCEBERNSTEIN L.P. - SEC SCHEDULE 13G Passive Investment

SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* Aemetis Inc (Name of Issuer) Common Stock (Title of Class of Securities) 00770K202 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designa

February 14, 2024 EX-10.1

Fifth Waiver and Amendment to Series A Preferred Unit Purchase Agreement, effective as of February 8, 2024, by and among Aemetis Biogas LLC, Protair X Americas, Inc., and Third Eye Capital Corporation.

Exhibit 10.1 FIFTH WAIVER AND AMENDMENT TO SERIES A PREFERRED UNIT PURCHASE AGREEMENT This Fifth Waiver and Amendment to Series A Preferred Unit Purchase Agreement (this “Amendment”), effective as of February 8, 2024 (“Effective Date”), is made by and among (i) AEMETIS BIOGAS LLC, a Delaware limited liability company (“ABGL” or “COMPANY”), (ii) PROTAIR-X AMERICAS, INC., a Delaware corporation and

February 13, 2024 SC 13G/A

AMTX / Aemetis, Inc. / Grantham, Mayo, Van Otterloo & Co. LLC - GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC / AEMETIS INC -- SCHEDULE 13G/A(#1) Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) * Aemetis Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 00770K202 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which this Schedule

December 29, 2023 EX-10.1

Term Loan Agreement dated as of December 22, 2023, by and among Aemetis Biogas 1 LLC, Aemetis Biogas Holdings LLC, and Greater Nevada Credit Union.

Exhibit 10.1 TERM LOAN AGREEMENT THIS TERM LOAN AGREEMENT (“Loan Agreement” or “Agreement”) is executed to be effective as of the 22nd day of December, 2023, by and between Greater Nevada Credit Union, a domestic nonprofit cooperative corporation organized under the laws of the State of Nevada (together with its successors and assigns, the “Lender”); Aemetis Biogas 1 LLC, a limited liability compa

December 29, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 22, 2023 Aemetis, Inc. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 22, 2023 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 State or other jurisdiction of incorporation Commission File Numbe

December 13, 2023 424B3

Aemetis, Inc. 126,008 shares of Common Stock for Sale by the Selling Stockholders

Filed Pursuant to Rule 424(b)(3) Registration No. 333-275888 Prospectus Aemetis, Inc. 126,008 shares of Common Stock for Sale by the Selling Stockholders This prospectus relates to the offer and sale from time to time by the selling stockholders identified in this prospectus or a supplement hereto of 126,008 shares of common stock, par value $0.001 per share (the “Common Stock”), of Aemetis, Inc.

December 7, 2023 CORRESP

Aemetis, Inc. 20400 Stevens Creek Blvd., Suite 700 Cupertino, CA 95014

Aemetis, Inc. 20400 Stevens Creek Blvd., Suite 700 Cupertino, CA 95014 December 7, 2023 Via EDGAR Transmission U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-6010 Attn: Sarah Sidwell Re: Aemetis, Inc. Registration Statement on Form S-1 Filed December 5, 2023 File No. 333-275888 Dear Ms. Sidwell: In accordance with Rule 461 of Regul

December 5, 2023 EX-FILING FEES

Filing Fee Table

Exhibit 107 CALCULATION OF FILING FEE TABLE S-1 (Form Type) Aemetis, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit (2) Maximum Aggregate Offering Price Fee Rate Amount of Registration

December 5, 2023 S-1

As filed with the Securities and Exchange Commission on December 5, 2023

As filed with the Securities and Exchange Commission on December 5, 2023 No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 2860 26-1407544 (State or other jurisdiction of incorporation or organization) (Primary Standard Indust

November 22, 2023 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2023 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Nu

November 21, 2023 424B5

$300,000,000 Aemetis, Inc. Common Stock

Filed Pursuant to Rule 424(b)(5) Registration No. 333-258322 SUPPLEMENT NO. 1 DATED NOVEMBER 20, 2023 To Prospectus Supplement Dated August 18, 2021 as amended by Amendment No. 1, dated November 30, 2021 (To Prospectus dated July 30, 2021) $300,000,000 Aemetis, Inc. Common Stock This Supplement No. 1 to Prospectus Supplement, or this supplement, supplements certain information contained in our pro

November 9, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-3647

November 9, 2023 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2023 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Num

November 9, 2023 EX-99.1

Aemetis Reports Third Quarter 2023 Financial Results Reports Net Income of $30.7 million and Basic EPS of $0.79

Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Investor Relations/Media Contact: Todd Waltz (408) 213-0940 [email protected] Aemetis Reports Third Quarter 2023 Financial Results Reports Net Income of $30.7 million and Basic EPS of $0.79 CUPERTINO, Calif. – November 9, 2023 - Aemetis, Inc. (NASDAQ: AMTX), a renewabl

November 9, 2023 EX-10.1

Fourth Waiver and Amendment to Series A Preferred Unit Purchase Agreement, effective as of November 8, 2023, by and among Aemetis Biogas LLC, Protair X Americas, Inc., and Third Eye Capital Corporation.

Exhibit 10.1 FOURTH WAIVER AND AMENDMENT TO SERIES A PREFERRED UNIT PURCHASE AGREEMENT This Fourth Waiver and Amendment to Series A Preferred Unit Purchase Agreement (this “Amendment”), effective as of November 8, 2023 (“Effective Date”) , is made by and among (i) AEMETIS BIOGAS LLC, a Delaware limited liability company (“ABGL” or “COMPANY”), (ii) PROTAIR-X AMERICAS, INC., a Delaware corporation a

October 30, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 24, 2023

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 24, 2023 AEMETIS, INC. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or Other Jurisdiction of Incorporation) (Commission File Num

October 6, 2023 EX-99.1

Aemetis Biogas Closes $53 Million Sale of IRA Tax Credits Tax credits generated by investment in negative carbon intensity renewable natural gas production; additional $800 million of IRA investment and production tax credits expected in the next fou

EXHIBIT 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Investor Relations/Media Contact: Todd Waltz (408) 213-0940 [email protected] Aemetis Biogas Closes $53 Million Sale of IRA Tax Credits Tax credits generated by investment in negative carbon intensity renewable natural gas production; additional $800 million of IRA inv

October 6, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 29, 2023

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 29, 2023 AEMETIS, INC. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or Other Jurisdiction of Incorporation) (Commission File N

August 30, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 24, 2023 AEMETIS, INC. (Ex

-12-31 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 24, 2023 AEMETIS, INC. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or Other Jurisdiction of Incorporation) (Commission Fi

August 30, 2023 EX-3.1

Amended and Restated Bylaws

Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF AEMETIS, INC. (A DELAWARE CORPORATION) AS OF AUGUST 24, 2023 TABLE OF CONTENTS Page ARTICLE 1 Offices 1 1.1 Registered Office1 1.2 Other Offices1 ARTICLE 2 Meeting of Stockholders 1 2.1 Place of Meeting1 2.2 Annual Meeting1 2.3 Special Meetings2 2.4 Notice of Meetings2 2.5 List of Stockholders2 2.6 Organization and Conduct of Business3 2.7 Quorum3 2.8 Adj

August 28, 2023 EX-10.1

Employment Agreement, dated August 28, 2023, with J. Michael Rockett.

Exhibit 10.1 AEMETIS, INC. J. Michael Rockett EMPLOYMENT AGREEMENT This Agreement is made by and between Aemetis, Inc. (the “Company”) and J. Michael Rockett (“Executive”) to be effective as of August 28, 2023 (the “Effective Date”). 1. Duties and Scope of Employment. a. Position; Duties. Executive’s employment with the Company pursuant to this Agreement is effective as of the Effective Date. Comm

August 28, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2023 AEMETIS, INC. (Ex

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2023 AEMETIS, INC. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or Other Jurisdiction of Incorporation) (Commission File Numb

August 28, 2023 EX-99.1

Aemetis Appoints J. Michael Rockett as Executive Vice President, General Counsel and Corporate Secretary

Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 [email protected] Aemetis Appoints J. Michael Rockett as Executive Vice President, General Counsel and Corporate Secretary CUPERTINO, Calif. – August 28, 2023 – Aemetis, Inc. (NASDAQ: AMTX), a renewable natur

August 4, 2023 EX-10.2

Amendment No. 1 to the Fuel Ethanol Purchase and Sale Agreement, effective as of May 30, 2023, by and between Aemetis Advanced Fuel Keyes, Inc. and Murex LLC.

Exhibit 10.2 Amendment No. 1 (“Amendment No. 1”) to Fuel Ethanol Purchase and Sale Agreement This Amendment No. 1 to the Fuel Ethanol Purchase and Sale Agreement (the “Amendment”) is effective May 30, 2023 (the “Effective Date”) between Murex LLC, a Texas limited liability company (“Buyer”), with offices at 7160 North Dallas Parkway, Suite 300, Plano, Texas 75024, and Aemetis Advanced Fuel Keyes,

August 4, 2023 EX-10.3

Amendment and Waiver No. 2 to Credit Agreement, effective as of August 1, 2023, by and among Goodland Advanced Fuels, Inc., Aemetis Carbon Capture, Inc., and Third Eye Capital Corporation, as agent for MBI/TEC Private Debt Opportunities Fund II, LP, and acknowledged and agreed by the guarantors listed on the signature page thereto.

Exhibit 10.3 AMENDMENT AND WAIVER NO. 2 TO CREDIT AGREEMENT This Amendment and Waiver No. 2 to Credit Agreement (this “Amendment”), is dated as of August 1, 2023 (the “Effective Date”), by and among (i) GOODLAND ADVANCED FUELS, INC., a Delaware corporation and AEMETIS CARBON CAPTURE, INC. (each, a “Borrower”) and (ii) THIRD EYE CAPITAL CORPORATION, an Ontario corporation (the “Agent”), as agent fo

August 4, 2023 EX-10.1

Limited Waiver and Amendment No. 27 to Amended and Restated Note Purchase Agreement, dated as of May 16, 2023, by and among Aemetis, Inc.; Aemetis Advanced Fuels Keyes, Inc.; Aemetis Facility Keyes, Inc.; Third Eye Capital Corporation, an Ontario corporation, as agent for Third Eye Capital Credit Opportunities Fund – Insight Fund, Ninepoint – TEC Private Credit Fund, Ninepoint – TEC Private Credit Fund II, and MBI/TEC Private Debt Open-End Trust Fund.

Exhibit 10.1 LIMITED WAIVER AND AMENDMENT NO. 27 TO AMENDED AND RESTATED NOTE PURCHASE AGREEMENT This Limited Waiver and Amendment No. 27 to Amended and Restated Note Purchase Agreement (this “Amendment”), is signed May 16, 2023 and made effective as of April 1, 2023, is made by and among (i) AEMETIS ADVANCED FUELS KEYES, INC., a Delaware corporation (“AEFK”), AEMETIS FACILITY KEYES, INC., a Delaw

August 4, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36475 AE

August 3, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2023 Aemetis, Inc. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2023 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Numbe

August 3, 2023 EX-99.1

Aemetis Reports Second Quarter 2023 Financial Results India Biodiesel Generates Revenues of $33.6 million from Supply to India Oil Marketing Companies

Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 [email protected] Aemetis Reports Second Quarter 2023 Financial Results India Biodiesel Generates Revenues of $33.6 million from Supply to India Oil Marketing Companies CUPERTINO, Calif. – August 3, 2023 - Ae

July 31, 2023 EX-10.1

Construction and Term Loan Agreement, dated as of July 28, 2023, by and among Magnolia Bank Incorporated, Aemetis Biogas 2 LLC, and Aemetis Biogas Holdings LLC.

Exhibit 10.1 CONSTRUCTION & TERM LOAN AGREEMENT THIS CONSTRUCTION & TERM LOAN AGREEMENT (“Loan Agreement” or “Agreement”) is executed to be effective as of the 28th day of July, 2023, by and between Magnolia Bank, Incorporated, a domestic banking corporation organized under the laws of the Commonwealth of Kentucky (together with its successors and assigns, the “Lender”); Aemetis Biogas 2 LLC, a li

July 31, 2023 EX-99.1

Aemetis Biogas Closes $25 million USDA-Guaranteed Financing to Fund Digesters for Eight Additional Dairies to Produce Renewable Natural Gas AB-2 Phase Fully Funded with $34.4 million from 20-year $25 million USDA Loan and $9.4 million of Aemetis Fund

Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 [email protected] Aemetis Biogas Closes $25 million USDA-Guaranteed Financing to Fund Digesters for Eight Additional Dairies to Produce Renewable Natural Gas AB-2 Phase Fully Funded with $34.4 million from 20

July 31, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 28, 2023 AEMETIS, INC. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 28, 2023 AEMETIS, INC. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or Other Jurisdiction of Incorporation) (Commission File Number

July 5, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 27, 2023 Aemetis, Inc. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 27, 2023 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or Other Jurisdiction of Incorporation) (Commission File Number

July 5, 2023 EX-10.1

Third Waiver and Amendment to Series A Preferred Unit Purchase Agreement, dated as of May 31, 2023, by and among Aemetis Biogas LLC, Protair-X Americas, Inc. and Third Eye Capital Corporation.

THIRD WAIVER AND AMENDMENT TO SERIES A PREFERRED UNIT PURCHASE AGREEMENT This Third Waiver and Amendment to Series A Preferred Unit Purchase Agreement (this “Amendment”), is dated effective as of May 31, 2023, is made by and among (i) AEMETIS BIOGAS LLC, a Delaware limited liability company (“ABGL”), PROTAIR-X AMERICAS, INC.

May 26, 2023 EX-10.3

Second Amendment to the Keyes Ethanol and Corn Tank Lease, dated as of May 25, 2023, by and between J.D. Heiskell Holdings, LLC and Aemetis Advanced Fuels Keyes, Inc.

Exhibit 10.3 SECOND AMENDMENT TO THE KEYES ETHANOL AND CORN TANK LEASE This Second Amendment to the Keyes Ethanol and Corn Tank Lease (this “Amendment”) is entered into on this 25th day of May, 2023 (the “Effective Date”), by and between J.D. Heiskell Holdings, LLC, a California limited liability company d.b.a. J.D. Heiskell & Co. (“Lessee”) and Aemetis Advanced Fuel Keyes, Inc., a Delaware corpor

May 26, 2023 EX-10.2

Second Amendment to the Amended and Restated Heiskell Purchase Agreement, dated as of May 25, 2023, by and between J.D. Heiskell Holdings, LLC and Aemetis Advanced Fuels Keyes, Inc.

Exhibit 10.2 SECOND AMENDMENT TO THE AMENDED AND RESTATED HEISKELL PURCHASING AGREEMENT THIS SECOND AMENDMENT TO THE AMENDED AND RESTATED HEISKELL PURCHASING AGREEMENT (this “Amendment”) is made on this 25th day of May, 2023 (the “Effective Date”) by and between J.D. Heiskell Holdings, LLC, a California limited liability company doing business as J.D. Heiskell & Co. (“Heiskell”) and Aemetis Advanc

May 26, 2023 EX-10.1

Second Amendment to the Amended and Restated Aemetis Keyes Grain Procurement and Working Capital Agreement, dated as of May 25, 2023, by and between J.D. Heiskell Holdings, LLC and Aemetis Advanced Fuels Keyes, Inc.

Exhibit 10.1 SECOND AMENDMENT TO THE AMENDED AND RESTATED AEMETIS KEYES GRAIN PROCUREMENT AND WORKING CAPITAL AGREEMENT THIS SECOND AMENDMENT TO THE AMENDED AND RESTATED AEMETIS KEYES GRAIN PROCUREMENT AND WORKING CAPITAL AGREEMENT (this “Amendment”) is executed on this 25th day of May, 2023 (the “Effective Date”) by and between J.D. Heiskell Holdings, LLC, a California limited liability company d

May 26, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 25, 2023 AEMETIS, INC. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 25, 2023 AEMETIS, INC. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or Other Jurisdiction of Incorporation) (Commission File Number)

May 22, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 17, 2023 Aemetis, Inc. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 17, 2023 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Number)

May 5, 2023 EX-10.1

Limited Waiver and Amendment No. 26 to Amended and Restated Note Purchase Agreement, dated as of May 4, 2023, by and among Aemetis, Inc.; Aemetis Advanced Fuels Keyes, Inc.; Aemetis Facility Keyes, Inc.; and Third Eye Capital Corporation, an Ontario corporation, as agent for Ninepoint - TEC Private Credit Fund and Third Eye Capital Credit Opportunities Fund - Insight Fund.

LIMITED WAIVER AND AMENDMENT NO. 26 TO AMENDED AND RESTATED NOTE PURCHASE AGREEMENT This Limited Waiver and Amendment No. 26 to Amended and Restated Note Purchase Agreement (this “Amendment”), is dated as of May 4, 2023, is made by and among (i) AEMETIS ADVANCED FUELS KEYES, INC., a Delaware corporation (“AEFK”), AEMETIS FACILITY KEYES, INC., a Delaware corporation (“Keyes Facility”, together with

May 5, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36475 A

May 4, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2023 Aemetis, Inc. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2023 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Number)

May 4, 2023 EX-99.1

Aemetis Reports First Quarter 2023 Financial Results

Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 [email protected] Aemetis Reports First Quarter 2023 Financial Results CUPERTINO, Calif. – May 4, 2023 - Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels company focused on negative c

April 5, 2023 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive

March 27, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 24, 2023 AEMETIS, INC. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 24, 2023 AEMETIS, INC. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or Other Jurisdiction of Incorporation) (Commission File Numbe

March 27, 2023 EX-99.1

Investor Presentation

Exhibit 99.1

March 9, 2023 EX-10.100

Sixth Amended and Restated Promissory Note, dated as of March 6, 2023, by and among Aemetis, Inc.; Aemetis Advanced Fuels Keyes, Inc.; Aemetis Facility Keyes, Inc.; Third Eye Capital Corporation including Third Eye Capital Management Inc.

Exhibit 10.100 SIXTH AMENDED AND RESTATED PROMISSORY NOTE March 6, 2023 FOR VALUE RECEIVED, the undersigned, AEMETIS ADVANCED FUELS KEYES, INC., a Delaware corporation (“AAFK”), AEMETIS FACILITY KEYES, INC., a Delaware corporation (“Keyes Facility”, and together with AAFK, “Borrowers”) and AEMETIS, INC., a Nevada corporation (“Parent”, and together with Borrowers, the “Obligors”) jointly and sever

March 9, 2023 EX-21

Subsidiaries of the Company

Exhibit 21.1 List of Subsidiaries Biofuels Marketing, Inc. Aemetis Biochemicals, Inc. Aemetis Advanced Products Keyes, Inc. Aemetis Riverbank, Inc. Aemetis Advanced Products Riverbank, Inc. Aemetis Properties Riverbank, Inc. Aemetis Health Products, Inc. Aemetis Carbon Capture, Inc. Aemetis International, Inc. International Biofuels Ltd (Mauritius) Universal Biofuels Private Limited (India) Aemeti

March 9, 2023 EX-99.1

Aemetis Reports 2022 Fourth Quarter and Year-End Results Year over year revenues track the Five Year Plan by increasing 21% ($45 million) to $257 million

Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Contact: Todd Waltz Chief Financial Officer (408) 213-0925 [email protected] Aemetis Reports 2022 Fourth Quarter and Year-End Results Year over year revenues track the Five Year Plan by increasing 21% ($45 million) to $257 million CUPERTINO, Calif. – March 9, 2023 – Aemet

March 9, 2023 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 000-51354 AEMETIS, INC. (Exact name

March 9, 2023 EX-10.101

Limited Waiver and Amendment No. 25 to Amended and Restated Note Purchase Agreement, dated as of March 6, 2023, by and among Aemetis, Inc.; Aemetis Advanced Fuels Keyes, Inc.; Aemetis Facility Keyes, Inc.; and Third Eye Capital Corporation, an Ontario corporation, as agent for Ninepoint - TEC Private Credit Fund and Third Eye Capital Credit Opportunities Fund - Insight Fund.

Exhibit 10.101 LIMITED WAIVER AND AMENDMENT NO. 25 TO AMENDED AND RESTATED NOTE PURCHASE AGREEMENT This Limited Waiver and Amendment No. 25 to Amended and Restated Note Purchase Agreement (this “Amendment”), is dated as of March 6, 2023, is made by and among (i) AEMETIS ADVANCED FUELS KEYES, INC., a Delaware corporation (“AEFK”), AEMETIS FACILITY KEYES, INC., a Delaware corporation (“Keyes Facilit

March 9, 2023 S-8

As filed with the Securities and Exchange Commission on March 9, 2023.

FORM S-8 As filed with the Securities and Exchange Commission on March 9, 2023. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AEMETIS, INC. (Exact name of registrant as specified in its charter) Delaware 26-1407544 (State or other jurisdiction of incorporation or organization) (I.R.S. E

March 9, 2023 EX-FILING FEES

Filing Fee Table

EX-FILING FEES 4 ex484583.htm EXHIBIT FILING FEES Exhibit 107 CALCULATION OF REGISTRATION FEE Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount to be Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value $0.001 per share, to be issued pursuant to the Amended and Resta

March 9, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 9, 2023 Aemetis, Inc. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 9, 2023 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Number

February 14, 2023 SC 13G/A

AMTX / Aemetis Inc / Encompass Capital Advisors LLC Passive Investment

SC 13G/A 1 encompass-amtx123122a2.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Aemetis, Inc. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 00770K202 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appr

February 14, 2023 SC 13G/A

AMTX / Aemetis Inc / ALLIANCEBERNSTEIN L.P. - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Aemetis Inc (Name of Issuer) Common Stock (Title of Class of Securities) 00770K202 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule i

February 13, 2023 SC 13G

AMTX / Aemetis Inc / Grantham, Mayo, Van Otterloo & Co. LLC - GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC / AEMETIS INC -- SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) Aemetis Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 00770K202 (CUSIP Number) December 31st, 2022 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which this Schedule i

February 10, 2023 EX-99.1

Investor Presentation

Exhibit 99.1

February 10, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 6, 2023 Aemetis, Inc. (E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 6, 2023 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or Other Jurisdiction of Incorporation) (Commission File Num

February 10, 2023 EX-10.1

Second Waiver and Amendment to Series A Preferred Unit Purchase Agreement, dated as of February 6, 2023, by and among Aemetis Biogas LLC, Protair-X Americas, Inc. and Third Eye Capital Corporation.

Exhibit 10.1 SECOND WAIVER AND AMENDMENT TO SERIES A PREFERRED UNIT PURCHASE AGREEMENT This Second Waiver and Amendment to Series A Preferred Unit Purchase Agreement (this “Amendment”), is dated effective as of January 1, 2023, is made by and among (i) AEMETIS BIOGAS LLC, a Delaware limited liability company (“ABGL”), PROTAIR-X AMERICAS, INC., a Delaware corporation (the “Purchaser”), and (ii) THI

February 10, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 10, 2023 AEMETIS, INC. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 10, 2023 AEMETIS, INC. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or Other Jurisdiction of Incorporation) (Commission File Nu

January 19, 2023 CORRESP

S H E A R M A N & S T E R L I N G L L P 1460 El Camino Real Menlo Park, CA 94025

CORRESP 1 filename1.htm S H E A R M A N & S T E R L I N G L L P 1460 El Camino Real Menlo Park, CA 94025 +1.650.838.3600 January 19, 2023 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, D.C. 20549 Attention: Jeanne Baker and Terrence O’Brien Re: Aemetis, Inc. Form 10-K for the Year Ended Dece

December 27, 2022 CORRESP

1460 El Camino Real Menlo Park, CA 94025

CORRESP 1 filename1.htm S h e a r m a n & S t e r l i n g L L P 1460 El Camino Real Menlo Park, CA 94025 +1.650.838.3600 December 27, 2022 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, D.C. 20549 Attention: Jeanne Baker and Terrence O’Brien Re: Aemetis, Inc. Form 10-K for the Year Ended Dec

November 7, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2022 ☐ TRANSITION REPORT PURSUAN

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-364

November 3, 2022 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2022 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Num

November 3, 2022 EX-99.1

Aemetis Reports Third Quarter 2022 Financial Results Revenue Increased 44% over Q3 2022; EPS was $(0.46), Excluding Unitholder Redemption Charge related to Biogas Series A Preferred Unit Investor

EXHIBIT 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Investor Relations/Media Contact: Todd Waltz (408) 213-0940 [email protected] Aemetis Reports Third Quarter 2022 Financial Results Revenue Increased 44% over Q3 2022; EPS was $(0.46), Excluding Unitholder Redemption Charge related to Biogas Series A Preferred Unit Investor CUP

October 28, 2022 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 28, 2022 AEMETIS, INC. (E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 28, 2022 AEMETIS, INC. (Exact name of registrant as specified in its charter) Nevada 001-36475 26-1407544 (State or Other Jurisdiction of Incorporation) (Commission File Numbe

October 28, 2022 EX-99.1

Investor Presentation

Exhibit 99.1

October 11, 2022 8-K

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 4, 2022 AEMETIS, INC. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or Other Jurisdiction of Incorporation) (Commission File Numb

October 11, 2022 EX-99.1

Aemetis Biogas Closes $25 million USDA Guaranteed Project Financing with Greater Commercial Lending for Dairy Farm Biogas Digesters and Pipeline to Produce Renewable Natural Gas Project Processes Methane From California Dairy Farms Into Renewable Nat

Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 [email protected] Aemetis Biogas Closes $25 million USDA Guaranteed Project Financing with Greater Commercial Lending for Dairy Farm Biogas Digesters and Pipeline to Produce Renewable Natural Gas Project Proc

October 11, 2022 EX-10.1

Construction Loan Agreement, dated as of October 4, 2022, among Aemetis Biogas 1 LLC, as borrower, Aemetis Biogas Holdings LLC, as guarantor and Greater Nevada Credit Union, as lender.

Exhibit 10.1 CONSTRUCTION LOAN AGREEMENT THIS CONSTRUCTION LOAN AGREEMENT (?Loan Agreement? or ?Agreement?) is executed to be effective as of the 4th day of October, 2022, by and between Greater Nevada Credit Union (?GNCU?), a domestic nonprofit cooperative corporation organized under the laws of the State of Nevada, for itself and as agent/nominee for other lending institutions having an interest

August 8, 2022 EX-10.2

Waiver and Amendment to Series A Preferred Unit Purchase Agreement, dated as of August 8, 2022, by and among Aemetis Biogas LLC, Protair-X Americas, Inc., and Third Eye Capital Corporation.

EXHIBIT 10.2 WAIVER AND AMENDMENT TO SERIES A PREFERRED UNIT PURCHASE AGREEMENT This Waiver and Amendment to Series A Preferred Unit Purchase Agreement (this ?Amendment?), is dated as of August 8, 2022, is made by and among (i) AEMETIS BIOGAS LLC, a Delaware limited liability company (?ABGL?), PROTAIR-X AMERICAS, INC., a Delaware corporation (the ?Purchaser?), and (ii) THIRD EYE CAPITAL CORPORATIO

August 8, 2022 EX-10.1

Limited Waiver and Amendment No. 24 to Amended and Restated Note Purchase Agreement, dated as of August 8, 2022, by and among Aemetis, Inc.; Aemetis Advanced Fuels Keyes, Inc.; Aemetis Facility Keyes, Inc.; and Third Eye Capital Corporation, an Ontario corporation, as agent for Ninepoint - TEC Private Credit Fund and Third Eye Capital Credit Opportunities Fund - Insight Fund.

EXHIBIT 10.1 LIMITED WAIVER AND AMENDMENT NO. 24 TO AMENDED AND RESTATED NOTE PURCHASE AGREEMENT This Limited Waiver and Amendment No. 24 to Amended and Restated Note Purchase Agreement (this ?Amendment?), is dated as of August 8, 2022, is made by and among (i) AEMETIS ADVANCED FUELS KEYES, INC., a Delaware corporation (?AEFK?), AEMETIS FACILITY KEYES, INC., a Delaware corporation (?Keyes Facility

August 8, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36475 AEMETIS, INC. (Exact

August 4, 2022 EX-99.1

Aemetis Reports Second Quarter 2022 Financial Results Revenue Increased 20% over Q2 2021

EXHIBIT 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Investor Relations/Media Contact: Todd Waltz (408) 213-0940 [email protected] Aemetis Reports Second Quarter 2022 Financial Results Revenue Increased 20% over Q2 2021 CUPERTINO, Calif. ? August 4, 2022 - Aemetis, Inc. (NASDAQ: AMTX), an international renewable natural gas and

August 4, 2022 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2022 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Numbe

June 2, 2022 8-K

Other Events, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 26, 2022 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Number)

May 16, 2022 EX-10.1

Limited Waiver and Amendment No. 23 to Amended and Restated Note Purchase Agreement, dated as of May 11, 2022, by and among Aemetis, Inc.; Aemetis Advanced Fuels Keyes, Inc.; Aemetis Facility Keyes, Inc.; and Third Eye Capital Corporation, an Ontario corporation, as agent for Ninepoint - TEC Private Credit Fund and Third Eye Capital Credit Opportunities Fund - Insight Fund.

EXHIBIT 10.1 LIMITED WAIVER AND AMENDMENT NO. 23 TO AMENDED AND RESTATED NOTE PURCHASE AGREEMENT This Limited Waiver and Amendment No. 23 to Amended and Restated Note Purchase Agreement (this ?Amendment?), is dated as of May 11, 2022, is made by and among (i) AEMETIS ADVANCED FUELS KEYES, INC., a Delaware corporation (?AEFK?), AEMETIS FACILITY KEYES, INC., a Delaware corporation (?Keyes Facility?,

May 16, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? FORM 10-Q ??????? ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36475 ???

May 12, 2022 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission file number: 001-36475 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission file number: 001-36475 NOTIFICATION OF LATE FILING (Check one): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-CEN ? Form N-CSR For Period Ended: March 31, 2022 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on

May 12, 2022 EX-99.1

Aemetis Reports First Quarter 2022 Financial Results Revenue Increased 22% over Q1 2021

EXHIBIT 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 [email protected] Aemetis Reports First Quarter 2022 Financial Results Revenue Increased 22% over Q1 2021 CUPERTINO, Calif. ? May 12, 2022 - Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable

May 12, 2022 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2022 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Number)

April 6, 2022 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive

March 10, 2022 EX-99.1

Aemetis Reports 2021 Fourth Quarter and Year-End Results Year over year revenues increase 28% by $46 million

EXHIBIT 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Contact: Todd Waltz Chief Financial Officer (408) 213-0925 [email protected] Aemetis Reports 2021 Fourth Quarter and Year-End Results Year over year revenues increase 28% by $46 million CUPERTINO, Calif. ? March 10, 2022 ? Aemetis, Inc. (NASDAQ: AMTX), a renewable natural

March 10, 2022 EX-FILING FEES

Filing Fee Table

EXHIBIT 107 Form S-8 (Form Type) Aemetis, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, $0.001 par value, to be issued purs

March 10, 2022 EX-21.1

Subsidiaries of the Registrant

Exhibit 21.1 List of Subsidiaries Biofuels Marketing, Inc. Aemetis Biochemicals, Inc. Aemetis Advanced Products Keyes, Inc. Aemetis Riverbank, Inc. Aemetis Advanced Products Riverbank, Inc. Aemetis Properties Riverbank, Inc. Aemetis Health Products, Inc. Aemetis Carbon Capture, Inc. Aemetis International, Inc. International Biofuels Ltd (Mauritius) Universal Biofuels Private Limited (India) Aemeti

March 10, 2022 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 Commission file number: 000-51354 AEM

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? FORM 10-K ??????? ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 Commission file number: 000-51354 AEMETIS, INC. (Exact name of registrant as specified in its charter) Delaware 26-1407544 (State or other jurisdiction of incorporation or

March 10, 2022 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2022 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Numbe

March 10, 2022 EX-10.94

Limited Waiver and Amendment No. 22 to Amended and Restated Note Purchase Agreement dated as of March 8, 2022, by and Among Aemetis Inc.; Aemetis Advanced Fuels Keyes, Inc.; Aemetis Facility Keyes, Inc.; Third Eye Capital Corporation, an Ontario corporation, as agent for Third Eye Capital Credit Opportunities Fund- Insight Fund, and Ninepoint Third Eye Capital Private Credit Fund.

EXHIBIT 10.94 LIMITED WAIVER AND AMENDMENT NO. 22 TO AMENDED AND RESTATED NOTE PURCHASE AGREEMENT This Limited Waiver and Amendment No. 22 to Amended and Restated Note Purchase Agreement (this ?Amendment?), is dated as of March 8, 2022, is made by and among (i) AEMETIS ADVANCED FUELS KEYES, INC., a Delaware corporation (?AEFK?), AEMETIS FACILITY KEYES, INC., a Delaware corporation (?Keyes Facility

March 10, 2022 S-8

As filed with the Securities and Exchange Commission on March 10, 2022.

As filed with the Securities and Exchange Commission on March 10, 2022. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AEMETIS, INC. (Exact name of registrant as specified in its charter) Delaware 26-1407544 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer

March 4, 2022 EX-10.1

Amended and Restated Credit Agreement, dated as of March 2, 2022

EXHIBIT 10.1 AMENDED AND RESTATED CREDIT AGREEMENT GOODLAND ADVANCED FUELS, INC., and AEMETIS CARBON CAPTURE, INC., as Borrowers and AEMETIS, INC., AEMETIS ADVANCED PRODUCTS KEYES, INC., AEMETIS ADVANCED FUELS KEYES, INC., AEMETIS PROPERTY KEYES, INC., AEMETIS RIVERBANK, INC., AEMETIS PROPERTIES RIVERBANK, INC., AEMETIS ADVANCED PRODUCTS RIVERBANK, INC., AEMETIS HEALTH PRODUCTS, INC., AEMETIS INTE

March 4, 2022 EX-4.2

Warrant to Purchase Stock, dated as of March 2, 2022 ("Carbon Revolving Line Warrant")

EXHIBIT 4.2 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY, S

March 4, 2022 EX-10.2

Amended and Restated General Security Agreement, dated as of March 2, 2022

EXHIBIT 10.2 AMENDED AND RESTATED GENERAL SECURITY AGREEMENT made by GOODLAND ADVANCED FUELS, INC., AEMETIS CARBON CAPTURE, INC., AEMETIS, INC., each as a Grantor, THE OTHER GRANTORS LISTED ON THE SIGNATURE PAGES, and THE OTHER GRANTORS FROM TIME TO TIME PARTY HERETO in favor of THIRD EYE CAPITAL CORPORATION, as Agent Dated as of March 2, 2022 TABLE OF CONTENTS Page ARTICLE I DEFINED TERMS 2 Secti

March 4, 2022 EX-10.4

Third Amended and Restated Guaranty, dated as of March 2, 2022

EXHIBIT 10.4 THIRD AMENDED AND RESTATED GUARANTY This THIRD AMENDED AND RESTATED GUARANTY (this ?Guaranty?), dated as of March 2, 2022, is made by Goodland Advanced Fuels, Inc., a Delaware corporation (?GAFI?), Aemetis Carbon Capture, Inc., a Nevada corporation (?ACCI?), Aemetis, Inc., a Nevada corporation (the ?Parent?), each as a guarantor, each other guarantor listed on the signature pages here

March 4, 2022 EX-4.1

Warrant to Purchase Stock, dated as of March 2, 2022 ("Fuels Revolving Line Warrant")

EXHIBIT 4.1 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY, S

March 4, 2022 EX-10.3

Intellectual Property Security Agreement Supplement, dated as of March 2, 2022

EXHIBIT 10.3 INTELLECTUAL PROPERTY SECURITY AGREEMENT SUPPLEMENT This INTELLECTUAL PROPERTY SECURITY AGREEMENT SUPPLEMENT (this ?IP Security Agreement Supplement?) dated as of March 2, 2022, is made by the Persons listed on the signature page hereof (the ?Grantors? and each a ?Grantor?) in favor of THIRD EYE CAPITAL CORPORATION, as administrative agent and collateral agent for and on behalf of the

March 4, 2022 EX-10.5

Amended and Restated Pledge Agreement, dated as of March 2, 2022

EXHIBIT 10.5 AMENDED AND RESTATED PLEDGE AGREEMENT made by AEMETIS, INC., AEMETIS INTERNATIONAL, INC., AE ADVANCED FUELS, INC., AEMETIS BIOFUELS, INC., AEMETIS AMERICAS, INC., AEMETIS ADVANCED PRODUCTS KEYES, INC., AEMETIS RIVERBANK, INC. each as a Pledgor, and THE OTHER PLEDGORS FROM TIME TO TIME PARTY HERETO in favor of THIRD EYE CAPITAL CORPORATION, as Agent Dated as of March 2, 2022 AMENDED AN

March 4, 2022 8-K

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 2, 2022 AEMETIS, INC. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or Other Jurisdiction of Incorporation) (Commission File Number

March 4, 2022 EX-99.1

Aemetis Closes New $100 Million Credit Facilities for Carbon Reduction Projects and Working Capital Funding; Repays $16 Million of Higher Interest Rate Debt Base Interest Rate of 8% for Capital Projects and 10% for Working Capital Line

EXHIBIT 99.1 External Investor Relations Company Investor Relations/ Contact: Media Contact: Kirin Smith Todd Waltz PCG Advisory Group (408) 213-0940 (646) 863-6519 [email protected] [email protected] Aemetis Closes New $100 Million Credit Facilities for Carbon Reduction Projects and Working Capital Funding; Repays $16 Million of Higher Interest Rate Debt Base Interest Rate of 8% for Capi

February 28, 2022 EX-99.1

Aemetis, Inc. (Nasdaq: AMTX) Leading the Production of Below Zero Carbon Intensity Renewable Natural Gas and Renewable Fuels For Airplanes, Trucks, Cars and Electric Vehicles February 28, 2022

EXHIBIT 99.1 Aemetis, Inc. (Nasdaq: AMTX) Leading the Production of Below Zero Carbon Intensity Renewable Natural Gas and Renewable Fuels For Airplanes, Trucks, Cars and Electric Vehicles February 28, 2022 This presentation contains forward-looking statements, including statements regarding our assumptions, projections, expectations, targets, intentions or beliefs about future events or other stat

February 28, 2022 EX-99.2

Aemetis Unveils 2022 Five Year Plan Targeting $1.5 Billion of Revenue and $461 Million of Adjusted EBITDA by 2026

EXHIBIT 99.2 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 [email protected] Aemetis Unveils 2022 Five Year Plan Targeting $1.5 Billion of Revenue and $461 Million of Adjusted EBITDA by 2026 CUPERTINO, CA ? February 28, 2022 ? Aemetis, Inc. (NASDAQ: AMTX), a leading

February 28, 2022 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2022 AEMETIS, INC. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or Other Jurisdiction of Incorporation) (Commission File Nu

February 15, 2022 SC 13G/A

AMTX / Aemetis Inc / Encompass Capital Advisors LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No.

February 14, 2022 SC 13G

AMTX / Aemetis Inc / ALLIANCEBERNSTEIN L.P. Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Aemetis Inc (Name of Issuer) Common Stock (Title of Class of Securities) 00770K202 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is

February 11, 2022 SC 13G/A

AMTX / Aemetis Inc / Portolan Capital Management, LLC - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d ?1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d?2. (Amendment No. 2 )* Aemetis, Inc. (Name of Issuer) Common (Title of Class of Securities) 00770K202 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of t

December 21, 2021 EX-10.2

Lease Disposition and Development Agreement, dated as of December 14, 2021, by and between Aemetis Properties Riverbank, Inc. and City of Riverbank, California

EXHIBIT 10.2 LEASE DISPOSITION AND DEVELOPMENT AGREEMENT by and between the CITY OF RIVERBANK, CALIFORNIA and AEMETIS PROPERTIES RIVERBANK, INC. for the RIVERBANK INDUSTRIAL COMPLEX Dated December 14, 2021 LEASE DISPOSITION AND DEVELOPMENT AGREEMENT This LEASE DISPOSITION AND DEVELOPMENT AGREEMENT (this ?Agreement?) is made and entered into effective as of December 14, 2021 (?Effective Date?), by

December 21, 2021 EX-10.3

Guaranty Agreement, dated as of December 14, 2021, by and between Aemetis, Inc. and City of Riverbank, California

EXHIBIT 10.3 GUARANTY AGREEMENT This GUARANTY AGREEMENT (?Agreement?) is made and entered into as of December 14, 2021 (?Effective Date?), by and between the City of Riverbank, California (?City?), and Aemetis, Inc., a Delaware corporation (?Guarantor?). City and Guarantor are sometimes referred to herein individually as a ?Party? and collectively as the ?Parties.? Recitals A. Concurrent with this

December 21, 2021 EX-10.4

Real Estate Purchase and Sale Agreement, dated as of December 14, 2021, by and between Aemetis Properties Riverbank, Inc. and City of Riverbank, California

EXHIBIT 10.4 REAL ESTATE PURCHASE AND SALE AGREEMENT This REAL ESTATE PURCHASE AND SALE AGREEMENT (this ?Agreement?) is made and entered into as of December 14, 2021 (?Effective Date?), by and between the CITY OF RIVERBANK, CALIFORNIA (?Seller?), and AEMETIS PROPERTIES RIVERBANK, a Delaware corporation (?Buyer). Seller and Buyer are sometimes referred to herein individually as a ?Party? and collec

December 21, 2021 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 14, 2021 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Nu

December 21, 2021 EX-10.1

Real Estate Purchase and Sale Agreement, dated as of December 14, 2021 by and between Aemetis Properties Riverbank, Inc. and City of Riverbank, California

EXHIBIT 10.1 PARCEL B REAL ESTATE PURCHASE AND SALE AGREEMENT This REAL ESTATE PURCHASE AND SALE AGREEMENT (this ?Agreement?) is made and entered into as of December 14, 2021 (?Effective Date?), by and between the CITY OF RIVERBANK, CALIFORNIA (?City?), and AEMETIS PROPERTIES RIVERBANK, INC. a Delaware corporation (?Buyer). City and Buyer are sometimes referred to herein individually as a ?Party?

December 1, 2021 424B5

$300,000,000 Aemetis, Inc. Common Stock

Filed Pursuant to Rule 424(b)(5) Registration No. 333-258322 AMENDMENT NO. 1 DATED NOVEMBER 30, 2021 To Prospectus Supplement Dated August 18, 2021 (To Prospectus dated July 30, 2021) $300,000,000 Aemetis, Inc. Common Stock This Amendment No. 1 to Prospectus Supplement, or this amendment, amends our prospectus supplement dated August 18, 2021 (as amended by the amendment, the prospectus supplement

November 12, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2021 ☐ TRANSITION REPORT PURSUAN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36475 AEMETIS, INC. (

November 12, 2021 POS AM

As filed with the Securities and Exchange Commission on November 10, 2021

As filed with the Securities and Exchange Commission on November 10, 2021 Registration No.

November 12, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 11, 2021 Aemetis, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Nu

November 12, 2021 EX-99.1

Aemetis, Inc. Reports Third Quarter 2021 Financial Results

EXHIBIT 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 [email protected] Aemetis, Inc. Reports Third Quarter 2021 Financial Results CUPERTINO, Calif. ? November 11, 2021 - Aemetis, Inc. (NASDAQ: AMTX), an advanced renewable fuels and biochemicals company, today announced

November 10, 2021 8-A12B/A

Amendment No. 1 to Form 8-A filed with the Commission on November 10, 2021

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-A/A (Amendment No. 1) FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 AEMETIS, INC. (Exact name of registrant as specified in its charter) Delaware 26-1407544 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identi

November 2, 2021 EX-3.1

Certificate of Incorporation

EXHIBIT 3.1

November 2, 2021 8-K

Material Modification to Rights of Security Holders, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 28, 2021 AEMETIS, INC. (Exact name of registrant as specified in its charter) Delaware 001-36475 26-1407544 (State or Other Jurisdiction of Incorporation) (Commission File Num

November 2, 2021 EX-99.2

Articles of Conversion, as filed with the Secretary of State of the State of Nevada on October 29, 2021.

EX-99.2 6 amtxex992.htm ADDITIONAL EXHIBITS EXHIBIT 99.2

November 2, 2021 EX-99.3

Certificate of Conversion, as filed with the Secretary of State of the State of Delaware on October 28, 2021.

EXHIBIT 99.3

November 2, 2021 EX-99.1

Plan of Conversion, dated October 1, 2021.

EXHIBIT 99.1

November 2, 2021 EX-3.2

Certificate of Designation of Series B Preferred Stock

EXHIBIT 3.2

November 2, 2021 EX-3.3

By Laws

EXHIBIT 3.3 BYLAWS OF AEMETIS, INC. (A DELAWARE CORPORATION) AS OF October 28, 2021 TABLE OF CONTENTS Page ARTICLE 1 Offices 1 1.1 Registered Office 1 1.2 Other Offices 1 ARTICLE 2 Meeting of Stockholders 1 2.1 Place of Meeting 1 2.2 Annual Meeting 1 2.3 Special Meetings 2 2.4 Notice of Meetings 2 2.5 List of Stockholders 2 2.6 Organization and Conduct of Business 2 2.7 Quorum 2 2.8 Adjournments 2

October 21, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 20, 2021 AEMETIS, INC. (Exact name of registrant as specified in its charter) NV 001-36475 26-1407544 (State or Other Jurisdiction of Incorporation) (Commission File Number) (

October 21, 2021 EX-99.1

Investor Presentation

EXHIBIT 99.1

October 18, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 14, 2021 Aemetis, Inc. (Exact name of registrant as specified in its charter) Nevada 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Numbe

September 30, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Other Events, 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 23, 2021 AEMETIS, INC. (Exact name of registrant as specified in its charter) Nevada 001-36475 26-1407544 (State or Other Jurisdiction of Incorporation) (Commission File Num

September 30, 2021 EX-99.1

Aemetis Signs Offtake Agreement with Delta Air Lines for 250 Million Gallons of Sustainable Aviation Fuel

EXHIBIT 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 [email protected] Aemetis Signs Offtake Agreement with Delta Air Lines for 250 Million Gallons of Sustainable Aviation Fuel CUPERTINO, CA ? September 30, 2021 ? Aemetis, Inc. (NASDAQ: AMTX), a renewable fuels

August 30, 2021 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 26, 2021

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 26, 2021 Aemetis, Inc. (Exact name of registrant as specified in its charter) Nevada 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Number

August 19, 2021 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 18, 2021

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 18, 2021 Aemetis, Inc. (Exact name of registrant as specified in its charter) Nevada 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Number

August 19, 2021 EX-1.1

Letter Agreement, dated August 18, 2021 between the Company and H.C. Wainwright & Co., LLC

EXHIBIT 1.2 August 18, 2021 Aemetis, Inc. 20400 Stevens Creek Blvd, Suite 700 Cupertino, California 95014 Attention: Eric McAfee Dear Mr. McAfee: Reference is made to the At Market Issuance Sales Agreement, dated as of January 26, 2021 (the ?ATM Agreement?), between Aemetis, Inc. (the ?Company?) and H.C. Wainwright & Co., LLC (?Wainwright?). This letter (the ?Amendment?) constitutes an agreement b

August 19, 2021 424B5

$300,000,000 Aemetis, Inc. Common Stock

Filed Pursuant to Rule 424(b)(5) Registration No. 333-258322 PROSPECTUS SUPPLEMENT (To Prospectus dated July 30, 2021) $300,000,000 Aemetis, Inc. Common Stock We have entered into an At Market Issuance Sales Agreement, or the sales agreement, with H.C. Wainwright & Co., LLC, or the distribution agent, dated January 26, 2021, as amended by that certain amendment agreement, dated as of the date of t

August 12, 2021 EX-99.1

Aemetis, Inc. Reports Second Quarter 2021 Financial Results

EX-99.1 2 amtxex991.htm PRESS RELEASE Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 [email protected] Aemetis, Inc. Reports Second Quarter 2021 Financial Results CUPERTINO, Calif. – August 12, 2021 - Aemetis, Inc. (NASDAQ: AMTX), an advanced renewable fuels and

August 12, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36475 AEMETIS, INC. (Exact

August 12, 2021 EX-10

Fourth Amended and Restated Promissory Note, dated as of August 9, 2021 by and among Aemetis, Inc.; Aemetis Advanced Fuels Keyes, Inc.; Aemetis Facility Keyes, Inc.; Third Eye Capital Corporation including Third Eye Capital Management Inc.

EXHIBIT 10.2 FOURTH AMENDED AND RESTATED PROMISSORY NOTE August 9, 2021 FOR VALUE RECEIVED, the undersigned, AEMETIS ADVANCED FUELS KEYES, INC., a Delaware corporation (?AAFK?), AEMETIS FACILITY KEYES, INC., a Delaware corporation (?Keyes Facility?, and together with AAFK, ?Borrowers?) and AEMETIS, INC., a Nevada corporation (?Parent?, and together with Borrowers, the ?Obligors?) jointly and sever

August 12, 2021 EX-10

Limited Waiver and Amendment No. 20 to Amended and Restated Note Purchase Agreement, dated as of August 9, 2021 by and among Aemetis, Inc.; Aemetis Advanced Fuels Keyes, Inc.; Aemetis Facility Keyes, Inc.; Third Eye Capital Corporation, an Ontario corporation, as agent for Third Eye Capital Credit Opportunities Fund - Insight Fund, and Ninepoint Third Eye Capital Private Credit Fund.

EXHIBIT 10.1 LIMITED WAIVER AND AMENDMENT NO. 20 TO AMENDED AND RESTATED NOTE PURCHASE AGREEMENT This Limited Waiver and Amendment No. 20 to Amended and Restated Note Purchase Agreement (this ?Amendment?), is dated as of August 9, 2021, is made by and among (i) AEMETIS ADVANCED FUELS KEYES, INC., a Delaware corporation (?AEFK?), AEMETIS FACILITY KEYES, INC., a Delaware corporation (?Keyes Facility

August 12, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2021 Aemetis, Inc. (Exact name of registrant as specified in its charter) Nevada 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Number

August 11, 2021 CORRESP

Aemetis, Inc. 20400 Stevens Creek Boulevard, Suite 700 Cupertino, California 95014 August 11, 2021

Aemetis, Inc. 20400 Stevens Creek Boulevard, Suite 700 Cupertino, California 95014 August 11, 2021 Via EDGAR Transmission U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-6010 Attn: Laura Crotty Re: Aemetis, Inc.Registration Statement on Form S-3 Filed July 30, 2021File No. 333-258322 Dear Ms. Crotty: In accordance with Rule 461 of R

July 30, 2021 S-3

As filed with the Securities and Exchange Commission on July 30, 2021 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Aemetis, Inc. (Exact

As filed with the Securities and Exchange Commission on July 30, 2021 Registration No.

July 29, 2021 DEFR14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ( X ) Filed by a Party other than the Registrant ( ) Check the appropriate box: ( ) Preliminary Proxy Statement ( ) Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) (

July 23, 2021 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ( X ) Filed by a Party other than the Registrant ( ) Check the appropriate box: ( ) Preliminary Proxy Statement ( ) Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) (X

July 13, 2021 PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ( X ) Filed by a Party other than the Registrant ( ) Check the appropriate box: (X) Preliminary Proxy Statement ( ) Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) (

June 14, 2021 EX-10.1

Fuel Ethanol Purchase and Sale Agreement, effective as of June 9, 2021, by and between Aemetis Advanced Fuel Keyes, Inc. and Murex LLC.

Exhibit 10.1 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. FUEL ETHANOL PURCHASE AND SALE AGREEMENT BETWEEN AEMETIS ADVANCED FUELS KEYES, INC. AND MUREX LLC Effective Date: October 1, 2021 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MA

June 14, 2021 EX-99.1

Aemetis Signs $200 million Agreement for Low Carbon Biofuels to be Delivered in 2021-23 Low Carbon Biofuels to Be Produced from Solar, MVR, Mitsubishi Zebrex™ Membrane Dehydration System and other Technology and Energy Efficiency Upgrades to Aemetis

Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 [email protected] Aemetis Signs $200 million Agreement for Low Carbon Biofuels to be Delivered in 2021-23 Low Carbon Biofuels to Be Produced from Solar, MVR, Mitsubishi Zebrex? Membrane Dehydration System and

June 14, 2021 8-K

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 9, 2021 AEMETIS, INC. (Exact name of registrant as specified in its charter) Nevada 001-36475 26-1407544 (State or Other Jurisdiction of Incorporation) (Commission File Number) (

May 24, 2021 SC 13G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Aemetis, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.

May 12, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2021 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? FORM 10-Q ??????? ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36475 ???

May 12, 2021 EX-99.1

Aemetis, Inc. Reports First Quarter 2021 Financial Results

Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 [email protected] Aemetis, Inc. Reports First Quarter 2021 Financial Results CUPERTINO, Calif. ? May 12, 2021 - Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels company focused on neg

May 12, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2021 Aemetis, Inc. (Exact name of registrant as specified in its charter) Nevada 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Number) (

April 30, 2021 10-K/A

Annual Report - 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? FORM 10-K/A Amendment No. 1 ??????? ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 Commission file number: 000-51354 AEMETIS, INC. (Exact name of registrant as specified in its charter) Nevada 26-1407544 (State or other jurisdiction of

April 21, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 21, 2021 AEMETIS, INC. (Exact name of registrant as specified in its charter) Nevada 001-36475 26-1407544 (State or Other Jurisdiction of Incorporation) (Commission File Number)

April 21, 2021 EX-99.2

Aemetis Updates Presentation of Five-Year Plan Targeting $1 Billion of Revenue by 2025 for BofA Securities RNG Investor Conference on April 21st

Exhibit 99.2 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 [email protected] Aemetis Updates Presentation of Five-Year Plan Targeting $1 Billion of Revenue by 2025 for BofA Securities RNG Investor Conference on April 21st CUPERTINO, CA ? April 21, 2021 ? Aemetis, Inc

April 21, 2021 EX-99.1

Exhibit 99.1

EX-99.1 2 amtxex991.htm INVESTOR PRESENTATION Exhibit 99.1

March 15, 2021 S-8

- PRIMARY DOCUMENT

As filed with the Securities and Exchange Commission on March 14, 2021. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AEMETIS, INC. (Exact name of registrant as specified in its charter) Nevada 26-1407544 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Id

March 15, 2021 EX-10.79

Promissory Note, dated as of March 10, 2021 by and among Aemetis, Inc.; Aemetis Advanced Fuels Keyes, Inc.; Aemetis Facility Keyes, Inc., Aemetis, Inc.; and Third Eye Capital Corporation, an Ontario corporation,

Exhibit 10.79 THIRD AMENDED AND RESTATED PROMISSORY NOTE March 14, 2021 FOR VALUE RECEIVED, the undersigned, AEMETIS ADVANCED FUELS KEYES, INC., a Delaware corporation (?AAFK?), AEMETIS FACILITY KEYES, INC., a Delaware corporation (?Keyes Facility?, and together with AAFK, ?Borrowers?) and AEMETIS, INC., a Nevada corporation (?Parent?, and together with Borrowers, the ?Obligors?) jointly and sever

March 15, 2021 10-K

Annual Report - ANNUAL REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? FORM 10-K ??????? ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 Commission file number: 000-51354 AEMETIS, INC. (Exact name of registrant as specified in its charter) Nevada 26-1407544 (State or other jurisdiction of incorporation or o

March 15, 2021 EX-21.1

List of Subsidiaries

Exhibit 21.1 List of Subsidiaries Biofuels Marketing, Inc. Aemetis Biochemicals, Inc. Aemetis Advanced Products Keyes, Inc. Aemetis Riverbank, Inc. Aemetis Advanced Products Riverbank, Inc. Aemetis Properties Riverbank, Inc. Aemetis Health Products, Inc. Aemetis International, Inc. International Biofuels Ltd (Mauritius) Universal Biofuels Private Limited (India) Aemetis Technologies, Inc. Aemetis

March 15, 2021 EX-10.80

Limited Waiver and Amendment No. 19 to Amended and Restated Note Purchase Agreement, dated as of March 14, 2021, by and among Aemetis, Inc.; Aemetis Advanced Fuels Keyes, Inc.; Aemetis Facility Keyes, Inc.; Third Eye Capital Corporation, an Ontario corporation, as agent for Third Eye Capital Credit Opportunities Fund – Insight Fund and Ninepoint.

Exhibit 10.80 LIMITED WAIVER AND AMENDMENT NO. 19 TO AMENDED AND RESTATED NOTE PURCHASE AGREEMENT This Limited Waiver and Amendment No. 19 to Amended and Restated Note Purchase Agreement (this ?Amendment?), is dated as of March 14, 2021, is made by and among (i) AEMETIS ADVANCED FUELS KEYES, INC., a Delaware corporation (?AEFK?), AEMETIS FACILITY KEYES, INC., a Delaware corporation (?Keyes Facilit

March 11, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 11, 2021 Aemetis, Inc. (Exact name of registrant as specified in its charter) Nevada 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Number)

March 11, 2021 EX-99.1

Aemetis Reports 2020 Fourth Quarter and Year-End Results

Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Contact: Todd Waltz Chief Financial Officer (408) 213-0925 [email protected] Aemetis Reports 2020 Fourth Quarter and Year-End Results CUPERTINO, Calif. – March 11, 2021 – Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels company focused on below ze

March 1, 2021 EX-99.1

Exhibit 99.1

Exhibit 99.1

March 1, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2021 AEMETIS, INC. (Exact name of registrant as specified in its charter) Nevada 001-36475 26-1407544 (State or Other Jurisdiction of Incorporation) (Commission File Number)

February 12, 2021 SC 13G/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d –1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d–2. (Amendment No. 1)* Aeme

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d ?1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d?2. (Amendment No. 1)* Aemetis, Inc. (Name of Issuer) Common (Title of Class of Securities) 00770K202 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of th

January 27, 2021 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits - CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2021 AEMETIS, INC. (Exact name of registrant as specified in its charter) Nevada 001-36475 26-1407544 (State or Other Jurisdiction of Incorporation) (Commission File Numbe

January 27, 2021 EX-1.1

At Market Issuance Sales Agreement, dated January 26, 2021, by and between Aemetis, Inc. and H.C. Wainwright & Co., LLC

Execution Version AEMETIS, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement January 26, 2021 H.C. Wainwright & Co., LLC 430 Park Avenue New York, NY 10022 Ladies and Gentlemen: Aemetis, Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (“Distribution Agent” and “HCW”) as follows: 1. Issuance and Sa

January 26, 2021 424B5

$84,000,000 Aemetis, Inc. Common Stock _________

Filed Pursuant to Rule 424(b)(5) Registration No. 333-248492 PROSPECTUS SUPPLEMENT (To Prospectus dated August 28, 2020) $84,000,000 Aemetis, Inc. Common Stock We have entered into an At the Market Issuance Sales Agreement, or the sales agreement, with H.C. Wainwright & Co., LLC, or the distribution agent, dated January 26, 2021, relating to the sale of our common stock offered by this prospectus

December 31, 2020 SC 13G

SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d –1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d–2. (Amendment No. )* Aemetis, Inc. (Name of Issuer) (Title of Class of Securities) (CUSIP Number)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d –1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d–2. (Amendment No. )* Aemetis, Inc. (Name of Issuer) Common (Title of Class of Securities) 00770K202 (CUSIP Number) December 22, 2020 (Date of Event Which Requires Filing of thi

November 12, 2020 10-Q

Quarterly Report - QUARTERLY REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36475

November 12, 2020 EX-99.1

Limited Waiver and Amendment No. 18 to Amended and Restated Note Purchase Agreement, dated as of November 5, 2020, by and among Aemetis, Inc.; Aemetis Advanced Fuels Keyes, Inc.; Aemetis Facility Keyes, Inc.; Third Eye Capital Corporation, an Ontario corporation, as agent for Third Eye Capital Credit Opportunities Fund – Insight Fund, and Sprott PC Trust.

Exhibit 99.1 LIMITED WAIVER AND AMENDMENT NO. 18 TO AMENDED AND RESTATED NOTE PURCHASE AGREEMENT This Limited Waiver and Amendment No. 18 to Amended and Restated Note Purchase Agreement (this “Amendment”), is dated as of November 5, 2020, is made by and among (i) AEMETIS ADVANCED FUELS KEYES, INC., a Delaware corporation (“AEFK”), AEMETIS FACILITY KEYES, INC., a Delaware corporation (“Keyes Facili

November 12, 2020 EX-99.1

Aemetis, Inc. Reports Third Quarter 2020 Financial Results

Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 [email protected] Aemetis, Inc. Reports Third Quarter 2020 Financial Results CUPERTINO, Calif. – November 12, 2020 - Aemetis, Inc. (NASDAQ: AMTX), an advanced renewable fuels and biochemicals company innovating the r

November 12, 2020 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition - CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2020 Aemetis, Inc. (Exact name of registrant as specified in its charter) Nevada 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Numb

October 1, 2020 424B5

$16,000,000 Aemetis, Inc. Common Stock

Filed Pursuant to Rule 424(b)(5) Registration No. 333-248492 PROSPECTUS SUPPLEMENT (To Prospectus dated August 28, 2020) $16,000,000 Aemetis, Inc. Common Stock We have entered into an At the Market Issuance Sales Agreement, or the sales agreement, with H.C. Wainwright & Co., LLC, or Wainwright, and Roth Capital Partners, LLC, or Roth and together with Wainwright, the distribution agents, dated Sep

October 1, 2020 EX-1.1

At the Market Issuance Sales Agreement, dated September 30, 2020 by and among the Company, H.C. Wainwright & Co., LLC and Roth Capital Partners, LLC.

EXHIBIT 1.1 AEMETIS, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement September 30, 2020 H.C. Wainwright & Co., LLC 430 Park Avenue New York, NY 10022 Roth Capital Partners, LLC 888 San Clemente Drive, 4th Floor Newport Beach, CA 92660 Ladies and Gentlemen: Aemetis, Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wain

October 1, 2020 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits - CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2020 AEMETIS, INC. (Exact name of registrant as specified in its charter) Nevada 001-36475 26-1407544 (State or Other Jurisdiction of Incorporation) (Commission File Num

October 1, 2020 S-8

- REGISTRATION STATEMENT

As filed with the Securities and Exchange Commission on September 30, 2020. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AEMETIS, INC. (Exact name of registrant as specified in its charter) Nevada 26-1407544 (State or other jurisdiction of incorporation or organization) (I.R.S. Employe

October 1, 2020 EX-10.1

FORM OF WARRANT TO PURCHASE COMMON STOCK OF AEMETIS, INC.

EXHIBIT 10.1 FORM OF WARRANT TO PURCHASE COMMON STOCK OF AEMETIS, INC. THIS WARRANT AND THE SHARES PURCHASABLE HEREUNDER HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR QUALIFICATION OR AN EXEMPTION THEREFRO

September 21, 2020 CORRESP

-

1460 EL CAMINO REAL2ND FLOORMENLO PARK, CA 94025-4110 +1.650.838.3600 September 21, 2020 VIA EDGAR Division of Corporation Finance Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: Aemetis, Inc. Registration Statement on Form S-3 Registration No. 333-248492 Ladies and Gentlemen: On behalf of Aemetis, Inc. (the “Company”), we hereby request acceleration by the Securitie

August 28, 2020 S-3

- FORM S-3

As filed with the Securities and Exchange Commission on August 28, 2020 Registration No.

August 28, 2020 S-8

- FORM S-8

As filed with the Securities and Exchange Commission on August 28, 2020. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AEMETIS, INC. (Exact name of registrant as specified in its charter) Nevada 26-1407544 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer I

August 18, 2020 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2020 AEMETIS, INC. (Exact name of registrant as specified in its charter) Nevada 001-36475 26-1407544 (State or Other Jurisdiction of Incorporation) (Commission File Number

August 13, 2020 10-Q

Quarterly Report - QUARTERLY REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36475 ————

August 13, 2020 EX-99.1

Aemetis, Inc. Reports Second Quarter 2020 Financial Results Earnings of $0.10 per Share; Net Income of $2.2 Million; Adjusted EBITDA of $11.2 Million Driven by Sales of High Grade Alcohol for Hand Sanitizer

Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 [email protected] Aemetis, Inc. Reports Second Quarter 2020 Financial Results Earnings of $0.10 per Share; Net Income of $2.2 Million; Adjusted EBITDA of $11.2 Million Driven by Sales of High Grade Alcohol for Hand S

August 13, 2020 EX-10.1

Limited Waiver and Amendment No. 17 to Amended and Restated Note Purchase Agreement, dated as of August 11, 2020, by and among Aemetis, Inc.; Aemetis Advanced Fuels Keyes, Inc.; Aemetis Facility Keyes, Inc.; Third Eye Capital Corporation, an Ontario corporation, as agent for Third Eye Capital Credit Opportunities Fund – Insight Fund, and Sprott PC Trust.

Exhibit 10.1 LIMITED WAIVER AND AMENDMENT NO. 17 TO AMENDED AND RESTATED NOTE PURCHASE AGREEMENT This Limited Waiver and Amendment No. 17 to Amended and Restated Note Purchase Agreement (this “Amendment”), is dated as of August , 2020, is made by and among (i) AEMETIS ADVANCED FUELS KEYES, INC., a Delaware corporation (“AEFK”), AEMETIS FACILITY KEYES, INC., a Delaware corporation (“Keyes Facility”

August 13, 2020 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 13, 2020 Aemetis, Inc. (Exact name of registrant as specified in its charter) Nevada 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Number

June 9, 2020 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 4, 2020 Aemetis, Inc. (Exact name of registrant as specified in its charter) Nevada 001-36475 26-1407544 (State or other jurisdiction of incorporation) (Commission File Number) (

May 14, 2020 10-Q

Quarterly Report - QUARTERLY REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36475 ———

May 14, 2020 EX-10.2

FIRST AMENDMENT TO THE AMENDED AND RESTATED AEMETIS KEYES GRAIN PROCUREMENT AND WORKING CAPITAL AGREEMENT

Exhibit 10.2 FIRST AMENDMENT TO THE AMENDED AND RESTATED AEMETIS KEYES GRAIN PROCUREMENT AND WORKING CAPITAL AGREEMENT THIS FIRST AMENDMENT TO THE AMENDED AND RESTATED AEMETIS KEYES GRAIN PROCUREMENT AND WORKING CAPITAL AGREEMENT (this “Amendment”) is executed on this 13th day of May, 2020 (the “Effective Date”) by and between J.D. Heiskell Holdings, LLC, a California limited liability company d.b

May 14, 2020 EX-99.1

Aemetis, Inc. Reports First Quarter 2020 Financial Results

Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 [email protected] Aemetis, Inc. Reports First Quarter 2020 Financial Results CUPERTINO, Calif. – May 14, 2020 - Aemetis, Inc. (NASDAQ: AMTX), an advanced renewable fuels and biochemicals company, today announ

May 14, 2020 EX-10.1

FIRST AMENDMENT TO THE AMENDED AND RESTATED HEISKELL PURCHASING AGREEMENT

Exhibit 10.1 FIRST AMENDMENT TO THE AMENDED AND RESTATED HEISKELL PURCHASING AGREEMENT THIS FIRST AMENDMENT TO THE AMENDED AND RESTATED HEISKELL PURCHASING AGREEMENT (this “Amendment”) is made on this 13th day of May, 2020 (the “Effective Date”) by and between J.D. Heiskell Holdings, LLC, a California limited liability company doing business as J.D. Heiskell & Co. (“Heiskell”) and Aemetis Advanced

May 14, 2020 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2020 Aemetis, Inc. (Exact name of registrant as specified in its charter) Nevada 000-51354 26-1407544 (State or other jurisdiction of incorporation) (Commission File Number) (

Other Listings
DE:DW51 €2.10
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista